Hycult Biotech

  1. The Factor H family: four specific unmet challenges that need to be resolved

    This review was written in light of the perspective of principal investigators of the SciFiMed Consortium: a consortium aiming to create a comprehensive analytical system for the quantitative and functional assessment of the entire FH protein family. The FH-family consists of FH, FHL-1 and the five FHR proteins which are important regulators of the Read more...
  2. SciFiMed: Screening of inFlammation to enable personalized Medicine.

    We are proud to be part the international research project SciFiMed: Screening of inFlammation to enable personalized Medicine. With this international and interdisciplinary team we work on furthering immunological research and aim to enable new treatment methods and new approaches for the field of drug development. Prof. Pauly, entrusted with Read more...
  3. Complement and Thromboinflammation in SARS-CoV-2:

    When our adaptive immune system fails or responds too slow in pandemics, we need to be able to rely on our host defense and innate immune system. It has not only become more relevant for now, but also for future infections. As within the current SARS-CoV-2 / Covid-19 pandemic it is evident that the innate immune system has a pivotal role Read more...
  4. Hycult Biotech is partner in CORVOS: a unique European consortium focusing on complement

    Read more...
  5. Did you know we actively participate in scientific projects?

    Looking for a SME partner for your project? Looking for a company with experience in scientific projects to discuss options and possibilities? Hycult Biotech participates in several scientific projects. Curious to find out which? Check this page.  Read more...
  6. RELENT: for a safer and more effective treatment of patients who suffer from autoimmunity

    Hycult Biotech is always eager to participate in research projects and to be the connection between science and industry by jointly developing tools for monitoring inflammatory and autoimmune diseases. As a participant in the RELENT (RELapses prevENTion in chronic autoimmune disease) consortium, Hycult Biotech has developed immunoassays that help Read more...
  7. Improved diagnostics and intervention strategies for chronic autoimmune diseases in H2020 project

    Hycult Biotech participates in new H2020 project aiming at improved diagnostics and intervention strategies for chronic autoimmune diseases.

     

    Read more...
  8. gC1qR levels indicative for progression in pancreatic cancer

    Read more...
  9. Activation of granulocytes, hallmark for acute inflammation, sepsis and allergic conditions.

    Basophils, eosinophils and neutrophils are the three cell types that belong to the granulocytes. Granulocytes are a type of white blood cells characterized by the presence of granules in their cytoplasm. The nucleus shaped into the usual three lobes are typical for a granulocyte. They are released by bone marrow under the influence of complement through a process called granulopoiesis. Activation of granulocytes play a central role in the pathogenesis of many autoimmune diseases and are an important clinical hallmark for acute inflammation, sepsis and allergic conditions. Granulocytes form the first line of defense to many pathogens by releasing antimicrobial peptide.

    Read more...

9 Items

Show per page